Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis
Main Authors: | Nirav N. Shah, Kwang Woo Ahn, Carlos Litovich, Anna Sureda, Mohamed A. Kharfan-Dabaja, Farrukh T. Awan, Siddhartha Ganguly, Usama Gergis, David Inwards, Reem Karmali, Alexsandr Lazaryan, Lazaros Lekakis, Pashna Munshi, Sunita Nathan, Ayman A. Saad, Melhem Solh, Amir Steinberg, Ravi Vij, William A. Wood, Timothy S. Fenske, Sonali Smith, Mehdi Hamadani |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-021-00472-w |
Similar Items
-
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis
by: Narendranath Epperla, et al.
Published: (2019-01-01) -
Hematopoietic cell transplantation: Training challenges and potential opportunities through networking and integration of modern technologies to the practice setting
by: Mohamed A. Kharfan-Dabaja, et al.
Published: (2017-12-01) -
Treatment of Del17p and/or aberrant TP53 chronic lymphocytic leukemia in the era of novel therapies
by: Hind Rafei, et al.
Published: (2018-03-01) -
Relapse of Hodgkin lymphoma after autologous hematopoietic cell transplantation: A current management perspective
by: Madiha Iqbal, et al.
Published: (2021-06-01) -
Autoimmune Demyelinating Polyneuropathy as a Manifestation of Chronic Graft-versus-Host Disease after Adult Cord Blood Transplantation in a Patient with Chronic Lymphocytic Leukemia
by: Fredrick Hogan, et al.
Published: (2014-01-01)